These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 8671970
21. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease. Cuppari L, Carvalho AB, Lobão RR, Martini LA, Cendoroglo M, Ventura RT, Draibe SA. Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657 [Abstract] [Full Text] [Related]
22. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients. Bozkaya G, Nart A, Uslu A, Onman T, Aykas A, Doğan M, Karaca B. Transplant Proc; 2008 Jul; 40(1):151-5. PubMed ID: 18261573 [Abstract] [Full Text] [Related]
23. [Alkaline phosphatase of bone origin in hemodialyzed patients. 110 assays]. Ureña P, Prieur P, Pétrover M. Presse Med; 1996 Oct 05; 25(29):1320-5. PubMed ID: 8942941 [Abstract] [Full Text] [Related]
25. [Correlation between osteocalcin and bone histomorphometry in children with chronic renal failure]. Weglarska J, Ziółkowska H, Pańczyk-Tomaszewska M, Sieniawska M. Pediatr Pol; 1995 Dec 05; 70(12):1011-5. PubMed ID: 8649939 [Abstract] [Full Text] [Related]
26. Total and bone-specific alkaline phosphatases in haemodialysis patients with chronic liver disease. Jean G, Souberbielle JC, Zaoui E, Lorriaux C, Mayor B, Hurot JM, Deleaval P, Chazot C. Clin Biochem; 2012 Apr 05; 45(6):436-9. PubMed ID: 22314198 [Abstract] [Full Text] [Related]
28. Bone alkaline phosphatase besides intact parathyroid hormone in hemodialysis patients--any advantage? Jorge C, Gil C, Possante M, Silva E, Andrade R, Santos N, Cruz A, Teixeira R, Ferreira A. Nephron Clin Pract; 2005 Apr 05; 101(3):c122-7. PubMed ID: 16015001 [Abstract] [Full Text] [Related]
29. Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. Solal ME, Sebert JL, Boudailliez B, Marie A, Moriniere P, Gueris J, Bouillon R, Fournier A. J Clin Endocrinol Metab; 1991 Sep 05; 73(3):516-24. PubMed ID: 1874930 [Abstract] [Full Text] [Related]
32. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients. Bervoets AR, Spasovski GB, Behets GJ, Dams G, Polenakovic MH, Zafirovska K, Van Hoof VO, De Broe ME, D'Haese PC. Am J Kidney Dis; 2003 May 05; 41(5):997-1007. PubMed ID: 12722034 [Abstract] [Full Text] [Related]
33. Association between very low PTH levels and poor survival rates in haemodialysis patients: results from the French ARNOS cohort. Jean G, Lataillade D, Genet L, Legrand E, Kuentz F, Moreau-Gaudry X, Fouque D, ARNOS study investigators. Nephron Clin Pract; 2011 May 05; 118(2):c211-6. PubMed ID: 21178378 [Abstract] [Full Text] [Related]
35. Correlation of bone alkaline phosphatase and iPTH with some basic biochemical markers in predialysis and dialysis patients. Milinković NL, Majkic-Singh NT, Ignjatović SD, Lezaić VD, Pejanović SD, Jovanovic DB. Clin Lab; 2012 May 05; 58(7-8):747-53. PubMed ID: 22997975 [Abstract] [Full Text] [Related]
36. Biochemical measurements in the prediction of histologic subtype of renal transplant bone disease in women. Parker CR, Blackwell PJ, Freemont AJ, Hosking DJ. Am J Kidney Dis; 2002 Aug 05; 40(2):385-96. PubMed ID: 12148113 [Abstract] [Full Text] [Related]